MedPath

A comparison of two additive drugs to conventional local anesthesia in patients undergoing upper limb surgeries under regional anaesthesia.

Phase 2
Conditions
Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2023/08/056862
Lead Sponsor
DEPARTMENT OF ANAESTHESIOLOGY AND CRITICAL CAREINSTITUTE OF NAVAL MEDICINE INHS ASVINI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA Grade I & II

Patient undergoing upper limb orthopaedic surgeries

Exclusion Criteria

1.Patients are unwilling

2.Patients with bleeding disorders,

3.Patients on anticoagulants,

4.Patients with neurological and musculoskeletal disease,

5.Infection at the site of injection

6.History of allergy to local anaesthetics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare:- <br/ ><br>(a)The onset of sensory and motor blockade. <br/ ><br>(b)The duration of sensory and motor blockade. <br/ ><br>Timepoint: (a)Immediately after positioning the patient supine and every 5 minutes to check for onset of sensory and motor blockade <br/ ><br>(b)In the post operative period NRS score for pain, SpO2, sensory and motor weakness, requirement of rescue analgesia, will be noted during following intervals: 0-2 hours, 4-6 hours, 6-12 hours, 12-24 hours.
Secondary Outcome Measures
NameTimeMethod
Intraop & post op side effects & complications <br/ ><br>Timepoint: Immediately after positioning of patient uptil the surgery is finished. <br/ ><br>In the post operative period, Basal hemodynamics (HR, NIBP) & SpO2, requirement of rescue analgesia, nausea, vomiting will be noted during following intervals: 0-2 hours, 4-6 hours, 6-12 hours, 12-24 hours.
© Copyright 2025. All Rights Reserved by MedPath